RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial.

The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial.

Add to Collection
2015 Oct Others Fist_Author_Year_PM

Full Author : ['Linjawi, Sultan', 'Sothiratnam, Radhakrishna', 'Sari, Ramazan', 'Andersen, Henning', 'Hiort, Line Conradsen', 'Rao, Paturi']
Journal Title : Primary care diabetes
Chapter : Section3
Journal Year : 2015
Cited by : Not Available

AIMS: Investigate efficacy and tolerability of intensifying diabetes treatment with once- or twice-daily biphasic insulin aspart 30 (BIAsp 30) added to sitagliptin, and twice-daily BIAsp 30 without sitagliptin in patients with type 2 diabetes (T2D) inadeq.....

Keywords : ["twicedaily biphasic insulin aspart biasp", "twicedaily biasp without sitagliptin", "type diabetes uncontrolle", "metforminthe trial", "sitagliptin", "sitagliptin", "study", "patient"]